Sen. Wyden Hails Start of Cost Containment Measures for Prescription Drugs Covered by Medicare
October 07, 2022
October 07, 2022
WASHINGTON, Oct. 7 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on Oct. 6, 2022:
Senate Finance Committee Chair Ron Wyden, D-Ore., today hailed the start of several of the Inflation Reduction Act's prescription drug provisions, in particular the policy that will force drug companies to pay a rebate back to Medicare if the price of a product rises faster than the rate of inflation.
"Starting this week, ther . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today hailed the start of several of the Inflation Reduction Act's prescription drug provisions, in particular the policy that will force drug companies to pay a rebate back to Medicare if the price of a product rises faster than the rate of inflation.
"Starting this week, ther . . .